Skip to main content
Log in

Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

Interleukin-4 receptors (IL-4Rs) are expressed on a wide variety of human cancer cells, and therefore it may be a good option to treat IL-4R-bearing tumors with IL-4-fusing immunotoxins. In this study, the gene encoding human interleukin-4 mutein cpIL-4(13D) was obtained through overlapping polymerase chain reaction. A chimeric immunotoxin was constructed by genetically fusing the mutein cpIL-4(13D) to a modified version of Pseudomonas exotoxin A (PE38KDEL) and was expressed in Escherichia coli AD494 (DE3). The expression level of the fusion protein was about 30% of the total bacterial protein assessed by SDS-PAGE analysis. After purification by affinity chromatography and anion exchange chromatography, the chimeric protein was tested for its cytotoxicity. Our data show that cpIL-4(13D)-PE38KDEL has improved cytotoxicity on IL-4R-bearing tumor cells in comparison with other IL-4-fusing immunotoxins and might be useful in treating tumors with a large number of IL-4Rs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Kreitman, R. J., Puri, R. K., and Pastan, I. (1995) Cancer Res., 55, 3357–3363.

    Google Scholar 

  2. Debinski, W., Puri, R. K., and Pastan, I. (1994) Int. J. Cancer, 58, 744–748.

    Google Scholar 

  3. Debinski, W., Puri, R. K., Kreitman, R. J., and Pastan, I. (1993) J. Biol. Chem., 268, 14065–14070.

    Google Scholar 

  4. Kreitman, R. J., Puri, R. K., and Pastan, I. (1994) Proc. Natl. Acad. Sci. USA, 91, 6889–6893.

    Google Scholar 

  5. Puri, R. K., Hoon, D. S., Leland, P., Snoy, P., Rand, R. W., Pastan, I., and Kreitman, R. J. (1996) Cancer Res., 56, 5631–5637.

    Google Scholar 

  6. Puri, R. K., Mehrotra, P. T., Leland, P., Kreitman, R. J., Siegel, J. P., and Pastan, I. (1994) J. Immunol., 152, 3693–3700.

    Google Scholar 

  7. Husain, S. R., Behari, N., Kreitman, R. J., Pastan, I., and Puri, R. K. (1998) Cancer Res., 58, 3649–3653.

    Google Scholar 

  8. Srivannaboon, K., Shanafelt, A. B., Todisco, E., Forte, C. P., Behm, F. G., Raimondi, S. C., Pui, C. H., and Campana, D. (2001) Blood, 97, 752–758.

    Google Scholar 

  9. Walter, M. R., Kood, W. J., Zhao, B. G., Cameron, R. P., Jr., Ealick, S. E., Walter, R. L., Jr., Reichert, P., Nagabhushan, T. L., Trotta, P. P., and Bugg, C. E. (1992) J. Biol. Chem., 267, 20371–20376.

    Google Scholar 

  10. Hage, T., Sebald, W., and Reinemer, P. (1999) Cell, 97, 271–281.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W.-F. Wu.

Additional information

Translated from Biokhimiya, Vol. 70, No. 1, 2005, pp. 77–84. Original Russian Text Copyright © 2005 by Cui, Ji, Lv, Wu. Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM04-086, October 31, 2004.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cui, JX., Ji, JF., Lv, AG. et al. Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity. Biochemistry (Moscow) 70, 62–68 (2005). https://doi.org/10.1007/PL00021758

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00021758

Key words

Navigation